Medical Oncologist
Clinical Trials & Access Programs
Will I Get a Placebo — Instead of Real Treatment?
The fear of receiving a sugar pill while your cancer goes untreated stops many patients from even asking about trials. In most cancer trials, that fear is not what the evidence supports.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Most trials compare, not withhold — The majority of cancer trials compare a new treatment against the current standard of care — not against nothing.
- Ethics rules apply in India too — ICMR guidelines and the Declaration of Helsinki prohibit placebo-only arms when an effective standard treatment already exists for your cancer.
- You are told the odds upfront — Informed consent must state the probability of being in a placebo group before you sign anything.
- You can leave at any time — Withdrawing from a trial does not affect your right to continue with standard cancer care.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
In most cancer trials, you will not receive placebo instead of treatment. When a placebo is used, it is given alongside active treatment — everyone in the trial receives the current standard of care. ICMR and international ethics guidelines prohibit placebo-only arms when an effective standard treatment exists for your cancer.
Is it true that some patients in trials get nothing?
In the vast majority of cancer trials, no one receives nothing — not even the control group. Most trials compare a new treatment against the best existing treatment.
When a placebo is used, it is added on top of standard care. One group gets standard care plus the new drug; the other gets standard care plus a placebo. No one in either group is left without active treatment.
A placebo-only arm is only permitted when no standard treatment exists for that cancer type. ICMR guidelines and the Declaration of Helsinki, which India follows, both require this. If an effective treatment exists, it must be given to everyone in the trial.
When is placebo used, and what does each group actually receive?
| Trial type | Experimental group receives | Control group receives | Pure placebo ever used? |
|---|---|---|---|
| New drug vs. current standard | New drug | Best current treatment | No |
| Add-on trial (new drug alongside standard care) | Standard care + new drug | Standard care + placebo | No — everyone gets standard care |
| Cancer with no established standard treatment | Experimental drug | Placebo | Possibly — disclosed fully in consent |
| Early-phase safety trial (Phase I) | Experimental drug at escalating doses | No control group | No |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Questions to ask before you sign a consent form
- What is the probability I will be in the placebo group? Ask for the exact allocation ratio.
- If a placebo is used, will I still receive my current standard treatment alongside it?
- What happens if my cancer worsens during the trial — will I be moved to active treatment?
- Will I be told which group I am in, and if not, when will I find out?
- What costs does the trial cover — the experimental drug, scans, blood tests, clinic visits?
- What out-of-pocket expenses will I still have? Does the trial reimburse travel or accommodation?
- Can I withdraw at any time, and what will my care look like if I do?
How does joining a clinical trial actually work?
Eligibility screening
Your oncologist checks whether your cancer type, stage, test results and general health fit the trial's criteria. Not every patient who wants to join will qualify, and being found ineligible does not affect your standard care.
Informed consent
A member of the trial team explains the trial in full — including the placebo probability, the risks, what is covered and your rights. You receive a written document and time to decide. Signing is never rushed, and you may bring a family member to the discussion.
Randomisation
If you join, you are assigned to a group — usually by computer, not by your oncologist. Neither you nor your doctor chooses which group you are in. This is how trials generate reliable evidence.
Treatment and monitoring
You receive your assigned treatment and are monitored more closely than in standard care. Blood tests, scans and clinic visits happen on a fixed schedule that the trial team coordinates.
Ongoing review and your right to exit
Independent safety committees review results as data accumulate. If a clear harm or benefit emerges early, the trial may stop or offer the better treatment to all groups. You may exit at any point without penalty, and your treating team remains responsible for your care.
Did you know?
Patients in clinical trials sometimes experience better outcomes than those receiving the same standard treatment outside of trials.
Researchers attribute this partly to the closer monitoring, earlier detection of changes, and faster clinical response that trial participation requires.
Source: ASCO Patient Education Resources on Clinical Trial Design
Explore 52 more Cost, Access, Trials & Choosing a Hospital topics
Clinical Trials & Access Programs
- Basket and Umbrella Trials: The New Way Trials Are Designed
- Eligibility Criteria: Why Patients Get Rejected From Trials
- How to Find Cancer Clinical Trials in India
- Phase 1, 2 and 3 Trials: What the Numbers Mean for You
- Risks, Consent and Your Right to Withdraw
- What Happens After a Trial Ends?
- What Is a Clinical Trial and Should You Join One?
- Who Pays for Treatment in a Clinical Trial?
- Will I Get a Placebo Instead of Real Treatment?
Cost, Insurance & Access in India
- Are Generic Targeted Therapy Drugs Safe and Effective?
- Biosimilars for Trastuzumab, Bevacizumab and Rituximab in India
- CGHS, ECHS, ESI and State Schemes for Cancer Drugs
- Can You Get Targeted Therapy in a Government Hospital?
- Compassionate Access and Expanded Access Programs Explained
- Cost of NGS Testing vs the Cost of Treating Blindly
- Cost of Targeted Therapy in India: Monthly Price Guide by Drug Class
- Does Ayushman Bharat Cover Targeted Therapy?
- Hidden Costs Nobody Warns You About in Cancer Treatment
- How to File a Cancer Treatment Insurance Claim Without Rejection
- How to Talk to Your Doctor About Affording Treatment
- Importing a Cancer Drug Not Available in India
- NGOs and Crowdfunding for Cancer Treatment in India
- Patient Assistance Programs for Targeted Therapy Drugs in India
- Section 80DDB and Tax Deductions for Cancer Treatment
- Total Cost of Care: Targeted Therapy vs Chemotherapy Compared
- What Happens If You Have to Stop Treatment Because of Cost?
- Will Health Insurance Pay for Oral Cancer Tablets Taken at Home?
Hospital Choice, Second Opinion & Decision Pages
- A Guide for International and NRI Patients Seeking Cancer Care in India
- Day Care Infusion Centres: What to Expect on Infusion Day
- Documents to Bring to Your First Oncology Consultation
- Follow-Up on Oral Targeted Therapy: In Person or Teleconsult?
- Getting a Second Opinion on Your Targeted Therapy Plan
- How a Molecular Tumour Board Reviews Your Case
- How to Choose a Hospital for Targeted Therapy in India
- Medical Oncologist vs Precision Oncology Specialist: Who Do You Need?
- Online and Teleconsultation Second Opinions: How They Work
- Red Flags: Signs Your Cancer Care May Not Be Up to Standard
- Transferring Your Care to Another Hospital Mid-Treatment
- What a Good Second Opinion Actually Checks: A 10-Point Audit
- What a Precision Oncology Program Should Include: A Checklist
- What to Ask Before Committing to a Cancer Treatment Plan
Work, Travel, Legal & Insurance Rights
- Buying Life or Health Insurance After a Cancer Diagnosis
- Can You Keep Working Full Time on Targeted Therapy?
- Disability Certificate for Cancer Patients in India: How to Apply
- Flying With Cancer: Fitness to Fly and Airline Rules
- Making a Will and Organising Documents During Serious Illness
- Managing Fatigue and Meetings: Practical Workday Strategies
- Planning a Holiday Around Your Treatment Schedule
- Returning to Work After a Treatment Break
- Should You Tell Your Employer About Your Cancer Diagnosis?
- Sick Leave and Employment Rights for Cancer Patients in India
- Travel Insurance When You Have Cancer
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
What happens if I am in the placebo group and my cancer gets worse?
Your trial team monitors you throughout, and you will not be left without options if your cancer worsens. Most trials have written rules that allow you to exit and move to standard treatment if you are not responding. The consent form must describe these rules — ask your team to explain them clearly before you sign. Joining a trial does not mean accepting whatever happens without recourse.
Will I have to pay for my treatment if I join a trial?
The experimental drug or intervention is typically provided at no cost to trial participants. Whether other costs — scans, blood tests, clinic visits, travel — are covered varies from trial to trial. Some trials reimburse travel and accommodation; others do not. Ask the trial team for a written breakdown of what is covered and what you would still need to pay before you agree. This is a reasonable question and a responsible trial team will answer it in full.
Can I leave a clinical trial if I change my mind?
Yes. Participation is voluntary and you may withdraw at any point without giving a reason. Leaving a trial does not affect your right to continue receiving standard cancer care. Your treating oncologist remains responsible for your care whether you stay in the trial or leave it.
Will I know which group I am in — the real treatment or the placebo group?
In a blinded trial, neither you nor your treating doctor is told during the trial. This is done so that expectations do not influence the result. After the trial ends, or when you leave, you are entitled to be told which group you were in. The consent form must explain whether the trial is blinded and when you will be unblinded — ask your team to walk you through this before you sign.
Are clinical trials in India properly regulated?
Yes. Trials in India are regulated by the Central Drugs Standard Control Organisation under the Drugs and Cosmetics Act, and must follow ICMR's National Ethical Guidelines for Biomedical and Health Research. Every trial requires approval from an independent ethics committee before it begins. Serious adverse events must be reported to the regulator. Regulation does not eliminate all risk — your team must discuss known and unknown risks with you — but it means you have defined legal protections throughout your participation.